Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges Uchechukwu K. SampsonSergio FazioMacRae F. Linton Statin Drugs (M Clearfield, Section Editor) 19 November 2011 Pages: 1 - 10
Treatment of Familial Hypercholesterolemia: Is There a Need Beyond Statin Therapy? Anna RaperDaniel M. KolanskyMarina Cuchel Statin Drugs (M Clearfield, Section Editor) 02 December 2011 Pages: 11 - 16
Initiation of Statin Therapy: Are There Age Limits? Dipan A. DesaiSammy ZakariaPamela Ouyang Statin Drugs (M Clearfield, Section Editor) 16 November 2011 Pages: 17 - 25
Role of C-Reactive Protein When Prescribing a Statin Scott Kinlay Statin Drugs (M Clearfield, Section Editor) 29 November 2011 Pages: 26 - 32
A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough Jeffrey G. Shanes Statin Drugs (M Clearfield, Section Editor) Open access 23 November 2011 Pages: 33 - 40
New Horizons for Cholesterol Ester Transfer Protein Inhibitors Gregory G. Schwartz Nonstatin Drugs (W Borden, Section Editor) 15 November 2011 Pages: 41 - 48
Niacin: The Evidence, Clinical Use, and Future Directions Todd C. VillinesAndrew S. KimAllen J. Taylor Nonstatin Drugs (W Borden, Section Editor) 27 October 2011 Pages: 49 - 59
Advances in Medical Therapy for Weight Loss and the Weight-Centric Management of Type 2 Diabetes Mellitus Leon I. IgelAmanda G. PowellLouis J. Aronne Nonstatin Drugs (W Borden, Section Editor) 24 November 2011 Pages: 60 - 69
Lipid Effects of Antihypertensive Medications Roderick DeanoMatthew Sorrentino Nonstatin Drugs (W Borden, Section Editor) 27 October 2011 Pages: 70 - 77
Novel Antiplatelet Therapies Luke KimKonstantinos CharitakisDmitriy N. Feldman Nonstatin Drugs (W Borden, Section Editor) 19 November 2011 Pages: 78 - 84
Pharmacologic Agents for Tobacco Dependence Treatment: 2011 Update J. Taylor HaysDavid D. McFaddenJon O. Ebbert Nonstatin Drugs (W Borden, Section Editor) 15 October 2011 Pages: 85 - 92
Erratum to: Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis Melissa Y. WeiTerry A. Jacobson Erratum 03 December 2011 Pages: 93 - 93